• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $WRBY

    Warby Parker Inc.

    Subscribe to $WRBY
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

    IPO Year: 2021

    Exchange: NYSE

    Website: warbyparker.com

    Recent Analyst Ratings for Warby Parker Inc.

    DatePrice TargetRatingAnalyst
    4/30/2025$17.00Sell → Neutral
    Citigroup
    4/17/2025$27.00Hold → Buy
    Loop Capital
    2/28/2025$28.00 → $30.00Outperform
    Telsey Advisory Group
    2/25/2025$26.00Neutral
    ROTH MKM
    2/5/2025$19.00 → $23.00Neutral → Sell
    Citigroup
    1/17/2025$23.00Outperform → In-line
    Evercore ISI
    11/19/2024$22.00 → $26.00Outperform
    Telsey Advisory Group
    11/8/2024$19.00 → $22.00Outperform
    Telsey Advisory Group
    11/7/2024Mkt Perform → Outperform
    William Blair
    10/21/2024$15.00 → $18.00Neutral → Buy
    Goldman
    See more ratings

    Warby Parker Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Warby Parker upgraded by Citigroup with a new price target

      Citigroup upgraded Warby Parker from Sell to Neutral and set a new price target of $17.00

      4/30/25 1:18:55 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker upgraded by Loop Capital with a new price target

      Loop Capital upgraded Warby Parker from Hold to Buy and set a new price target of $27.00

      4/17/25 8:27:42 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

      Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $30.00 from $28.00 previously

      2/28/25 8:48:26 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • ROTH MKM initiated coverage on Warby Parker with a new price target

      ROTH MKM initiated coverage of Warby Parker with a rating of Neutral and set a new price target of $26.00

      2/25/25 7:15:06 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker downgraded by Citigroup with a new price target

      Citigroup downgraded Warby Parker from Neutral to Sell and set a new price target of $23.00 from $19.00 previously

      2/5/25 8:04:30 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker downgraded by Evercore ISI with a new price target

      Evercore ISI downgraded Warby Parker from Outperform to In-line and set a new price target of $23.00

      1/17/25 7:52:34 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

      Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $26.00 from $22.00 previously

      11/19/24 7:59:49 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

      Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $22.00 from $19.00 previously

      11/8/24 8:03:45 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker upgraded by William Blair

      William Blair upgraded Warby Parker from Mkt Perform to Outperform

      11/7/24 3:12:20 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker upgraded by Goldman with a new price target

      Goldman upgraded Warby Parker from Neutral to Buy and set a new price target of $18.00 from $15.00 previously

      10/21/24 8:18:13 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    Warby Parker Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Warby Parker Announces First Quarter 2025 Results

      Net revenue increased 12% year over year to $224 million Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025. "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal. "Looking to the rest of the year, we'll leverage our diversified suppl

      5/8/25 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before market open on May 8, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 020310. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation

      4/17/25 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Target and Warby Parker Team Up to Bring Stylish, Affordable Eyewear to More Consumers

      New Warby Parker at Target shop-in-shops will offer guests designer-quality eyewear as well as contacts and eye exams Five shop-in-shops will debut in 2025 with plans to open more in the years aheadMINNEAPOLIS and NEW YORK, Feb. 27, 2025 /PRNewswire/ -- Target Corporation (NYSE:TGT) and Warby Parker (NYSE:WRBY) are partnering to bring designer-quality, affordable eyewear to even more consumers through the retailer's newest shop-in-shop, Warby Parker at Target. Each Warby Parker at Target shop-in-shop will offer products and services — including glasses, sunglasses, contacts, e

      2/27/25 7:15:00 AM ET
      $TGT
      $WRBY
      Department/Specialty Retail Stores
      Consumer Discretionary
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Fourth Quarter and Full Year 2024 Results

      Q4 net revenue increased 17.8% year over year; 2024 net revenue increased 15.2% year over year Active Customers increased 7.8% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2024. "Our strong 2024 results highlight the power of Warby Parker's brand and unmatched value proposition combined with our team's high-quality execution. We delivered on our ambitious goals to accelerate revenue growth, customer growth and glasses growth, all while maintaining operational discipline and expanding p

      2/27/25 6:45:00 AM ET
      $TGT
      $WRBY
      Department/Specialty Retail Stores
      Consumer Discretionary
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2024 will be released before market open on February 27, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 460770. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

      2/6/25 7:00:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Morgan Stanley Global Consumer & Retail Conference on Tuesday, December 3, 2024 at 11:45 a.m. Eastern Time. The presentation will be webcast live over the internet and can be accessed at https://investors.warbyparker.com/. An online archive will be available for a period of 90 days following the presentation. About Warby Parker Warby Parker (NYSE:WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City, the

      12/2/24 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Third Quarter 2024 Results

      Net revenue increased 13.3% year over year to $192.4 million; Company raises FY outlook Active Customers increased 5.6% on a trailing 12-month basis; Average Revenue per Customer increased 7.5% Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2024. "Warby Parker's Q3 performance is a direct result of our team's commitment to making progress on our strategic initiatives, in particular expanding our marketing efforts, investing in store expansion, and enhancing our holistic vision care offering," shared Co-Founder and Co-CEO Neil Blumen

      11/7/24 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce Third Quarter 2024 Financial Results November 7, 2024

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2024 will be released before market open on November 7, 2024. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 681992. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where pre

      10/17/24 7:00:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Participation in the Goldman Sachs 31st Annual Global Retailing Conference

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Goldman Sachs 31st Annual Global Retailing Conference on Thursday, September 5, 2024 at 8:55 a.m. Eastern Time. The presentation will be webcast live over the internet and can be accessed at https://investors.warbyparker.com/. An online archive will be available for a period of 90 days following the presentation. About Warby Parker Warby Parker (NYSE:WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City,

      9/3/24 8:00:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Second Quarter 2024 Results

      Net revenue increased 13.3% year over year to $188.2 million; Company raises FY outlook Active Customers increased 4.5%; Average Revenue per Customer increased 8.8% Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the second quarter ended June 30, 2024. "We're proud of the progress we're making on our core strategic initiatives to accelerate growth," shared Co-Founder and Co-CEO Dave Gilboa. "In Q2, we drove our fourth consecutive quarter of active customer growth and our highest ecommerce growth since Q1‘21." "Our strong results demonstrate Team Warby's ability to d

      8/8/24 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    Warby Parker Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cutler Joel E disposed of 5,656,571 shares (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/18/25 9:52:05 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Chief Financial Officer Miller Steven Clive sold $274,808 worth of shares (11,684 units at $23.52), was granted 15,128 shares, covered exercise/tax liability with 6,321 shares and converted options into 27,731 shares, increasing direct ownership by 14% to 204,727 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/6/25 6:02:10 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Gilboa David Abraham converted options into 3,271 shares, sold $4,772,513 worth of shares (202,968 units at $23.51), was granted 23,250 shares, covered exercise/tax liability with 12,858 shares and converted options into 201,088 shares, increasing direct ownership by 96% to 24,089 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/5/25 9:57:41 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Blumenthal Neil Harris was granted 23,250 shares, covered exercise/tax liability with 12,858 shares, converted options into 176,088 shares, sold $4,317,542 worth of shares (177,967 units at $24.26) and converted options into 3,271 shares, increasing direct ownership by 97% to 23,961 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/5/25 9:56:42 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Blumenthal Neil Harris converted options into 50,000 shares and sold $1,380,500 worth of shares (50,000 units at $27.61) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      2/3/25 5:59:20 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Blumenthal Neil Harris converted options into 300,000 shares and sold $7,542,000 worth of shares (300,000 units at $25.14) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      1/6/25 6:16:59 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Gilboa David Abraham sold $9,437,515 worth of shares (375,000 units at $25.17) and converted options into 375,000 shares (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      1/6/25 6:15:42 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Gilboa David Abraham converted options into 144,212 shares and sold $3,621,163 worth of shares (144,212 units at $25.11) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      12/26/24 5:00:47 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Blumenthal Neil Harris converted options into 93,946 shares and sold $2,356,166 worth of shares (93,946 units at $25.08) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      12/26/24 5:00:13 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Blumenthal Neil Harris converted options into 56,054 shares and sold $1,406,395 worth of shares (56,054 units at $25.09) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      12/20/24 5:01:32 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    Warby Parker Inc. SEC Filings

    See more
    • SEC Form 10-Q filed by Warby Parker Inc.

      10-Q - Warby Parker Inc. (0001504776) (Filer)

      5/8/25 5:10:13 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Warby Parker Inc. (0001504776) (Filer)

      5/8/25 6:46:05 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form DEFA14A filed by Warby Parker Inc.

      DEFA14A - Warby Parker Inc. (0001504776) (Filer)

      5/6/25 5:07:56 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form DEFA14A filed by Warby Parker Inc.

      DEFA14A - Warby Parker Inc. (0001504776) (Filer)

      4/28/25 4:38:12 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form DEF 14A filed by Warby Parker Inc.

      DEF 14A - Warby Parker Inc. (0001504776) (Filer)

      4/28/25 4:33:31 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form S-8 filed by Warby Parker Inc.

      S-8 - Warby Parker Inc. (0001504776) (Filer)

      2/27/25 5:00:06 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form 10-K filed by Warby Parker Inc.

      10-K - Warby Parker Inc. (0001504776) (Filer)

      2/27/25 4:53:33 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Warby Parker Inc. (0001504776) (Filer)

      2/27/25 6:49:08 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form 144 filed by Warby Parker Inc.

      144 - Warby Parker Inc. (0001504776) (Subject)

      1/10/25 4:31:24 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form 10-Q filed by Warby Parker Inc.

      10-Q - Warby Parker Inc. (0001504776) (Filer)

      11/7/24 9:02:10 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    Warby Parker Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors

      Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company") announced today the appointment of Ron Williams as Lead Director. "Ron's deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director," said Neil Blumenthal, co-Founder and co-CEO. The Company has also appointed a new independent director, Brad Singer, to its board of directors. Mr. Singer's appointment is effective today, August 1, 2024. "Brad brings a wealth of experience as a dynamic operator and investor," said Dav

      8/1/24 4:15:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    Warby Parker Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/14/24 5:08:23 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/14/24 1:30:16 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/12/24 10:40:28 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      9/10/24 10:30:07 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      7/10/24 4:30:10 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      6/7/24 10:14:20 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      5/10/24 10:03:20 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      2/14/24 10:04:37 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      2/13/24 5:17:30 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      2/13/24 4:56:25 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    Warby Parker Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Singer Bradley E bought $965,750 worth of shares (75,000 units at $12.88) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      8/14/24 4:52:02 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    Warby Parker Inc. Financials

    Live finance-specific insights

    See more
    • Warby Parker Announces First Quarter 2025 Results

      Net revenue increased 12% year over year to $224 million Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025. "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal. "Looking to the rest of the year, we'll leverage our diversified suppl

      5/8/25 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before market open on May 8, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 020310. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation

      4/17/25 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Fourth Quarter and Full Year 2024 Results

      Q4 net revenue increased 17.8% year over year; 2024 net revenue increased 15.2% year over year Active Customers increased 7.8% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2024. "Our strong 2024 results highlight the power of Warby Parker's brand and unmatched value proposition combined with our team's high-quality execution. We delivered on our ambitious goals to accelerate revenue growth, customer growth and glasses growth, all while maintaining operational discipline and expanding p

      2/27/25 6:45:00 AM ET
      $TGT
      $WRBY
      Department/Specialty Retail Stores
      Consumer Discretionary
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2024 will be released before market open on February 27, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 460770. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

      2/6/25 7:00:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Third Quarter 2024 Results

      Net revenue increased 13.3% year over year to $192.4 million; Company raises FY outlook Active Customers increased 5.6% on a trailing 12-month basis; Average Revenue per Customer increased 7.5% Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2024. "Warby Parker's Q3 performance is a direct result of our team's commitment to making progress on our strategic initiatives, in particular expanding our marketing efforts, investing in store expansion, and enhancing our holistic vision care offering," shared Co-Founder and Co-CEO Neil Blumen

      11/7/24 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce Third Quarter 2024 Financial Results November 7, 2024

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2024 will be released before market open on November 7, 2024. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 681992. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where pre

      10/17/24 7:00:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Second Quarter 2024 Results

      Net revenue increased 13.3% year over year to $188.2 million; Company raises FY outlook Active Customers increased 4.5%; Average Revenue per Customer increased 8.8% Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the second quarter ended June 30, 2024. "We're proud of the progress we're making on our core strategic initiatives to accelerate growth," shared Co-Founder and Co-CEO Dave Gilboa. "In Q2, we drove our fourth consecutive quarter of active customer growth and our highest ecommerce growth since Q1‘21." "Our strong results demonstrate Team Warby's ability to d

      8/8/24 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce Second Quarter 2024 Financial Results on August 8, 2024

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the second quarter ended June 30, 2024 will be released before market open on August 8, 2024. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 515887. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where present

      7/18/24 7:00:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces First Quarter 2024 Results

      Net revenue increased 16.3% year over year to $200.0 million; Company raises outlook Average Revenue per Customer increased 9.6% year over year to $296 Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2024. "We entered 2024 with higher ambitions for delivering on our key metrics and are proud of what the team accomplished in Q1–we drove our highest revenue quarter growth since 2021, up 16.3% year over year, while making significant progress to improve profitability," said Co-Founder and Co-CEO Neil Blumenthal. "Earlier this year, we

      5/9/24 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2024 will be released before market open on May 9, 2024. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 976307. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentati

      4/18/24 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care